User login
A supplement to Family Practice News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•What is Alpha-1 Antitrypsin Deficiency?
•AAT Deficiency is Widely Underrecognized
•Why Are Rates of Diagnosis So Low?
•Optimal Diagnosis and Management Strategies
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Leonard Fromer, MD
Assistant Clinical Professor, Family Medicine
David Geffen School of Medicine
University of California
Los Angeles
Dr. Fromer is a consultant for Talecris Biotherapeutics, Inc.
Copyright © 2009 Elsevier Inc.
A supplement to Family Practice News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•What is Alpha-1 Antitrypsin Deficiency?
•AAT Deficiency is Widely Underrecognized
•Why Are Rates of Diagnosis So Low?
•Optimal Diagnosis and Management Strategies
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Leonard Fromer, MD
Assistant Clinical Professor, Family Medicine
David Geffen School of Medicine
University of California
Los Angeles
Dr. Fromer is a consultant for Talecris Biotherapeutics, Inc.
Copyright © 2009 Elsevier Inc.
A supplement to Family Practice News. This supplement was supported by Talecris Biotherapeutics.
•Topics
•Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
•What is Alpha-1 Antitrypsin Deficiency?
•AAT Deficiency is Widely Underrecognized
•Why Are Rates of Diagnosis So Low?
•Optimal Diagnosis and Management Strategies
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures
Leonard Fromer, MD
Assistant Clinical Professor, Family Medicine
David Geffen School of Medicine
University of California
Los Angeles
Dr. Fromer is a consultant for Talecris Biotherapeutics, Inc.
Copyright © 2009 Elsevier Inc.
